Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Interpace Diag Group (IDXG)

Interpace Diag Group (IDXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 6,002
  • Shares Outstanding, K 4,370
  • Annual Sales, $ 40,210 K
  • Annual Income, $ 800 K
  • 60-Month Beta 0.68
  • Price/Sales 0.15
  • Price/Cash Flow 2.32
  • Price/Book N/A
Trade IDXG with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.10
  • Most Recent Earnings $0.13 on 05/09/24
  • Next Earnings Date 05/10/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1600 +18.10%
on 06/10/24
1.6000 -14.38%
on 06/04/24
-0.0800 (-5.52%)
since 05/10/24
3-Month
1.1600 +18.10%
on 06/10/24
2.6000 -47.31%
on 04/05/24
-0.3280 (-19.32%)
since 03/12/24
52-Week
0.7650 +79.08%
on 08/24/23
3.5400 -61.30%
on 07/11/23
+0.2200 (+19.13%)
since 06/12/23

Most Recent Stories

More News
TherapeuticsMD (TXMD) Reports Q3 Loss, Lags Revenue Estimates

TherapeuticsMD (TXMD) delivered earnings and revenue surprises of -53.43% and 30.74%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

TXMD : 2.05 (-1.44%)
IDXG : 1.3700 (-0.25%)
Organon (OGN) Q3 Earnings and Revenues Top Estimates

Organon (OGN) delivered earnings and revenue surprises of 17.86% and 2.94%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

OGN : 20.84 (+2.86%)
IDXG : 1.3700 (-0.25%)
CareDx (CDNA) Reports Q2 Loss, Lags Revenue Estimates

CareDx (CDNA) delivered earnings and revenue surprises of -62.50% and 3.05%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

CDNA : 15.29 (+2.69%)
IDXG : 1.3700 (-0.25%)
XpresSpa Group, Inc. (XSPA) Reports Q1 Loss, Tops Revenue Estimates

XpresSpa Group, Inc. (XSPA) delivered earnings and revenue surprises of 33.33% and 23.83%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

XSPA : 0.6550 (-5.65%)
IDXG : 1.3700 (-0.25%)
Interpace Biosciences Announces First Quarter 2022 Financial and Business Results

 ●Q1 Revenue of $10.4 million up 6% versus Prior Year ●Q1 Net Loss improved $2 million versus Prior Year ●Days Sales Outstanding (DSO) decreased by 27% ...

IDXG : 1.3700 (-0.25%)
Organon (OGN) Q1 Earnings and Revenues Beat Estimates

Organon (OGN) delivered earnings and revenue surprises of 25.95% and 3.88%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

OGN : 20.84 (+2.86%)
IDXG : 1.3700 (-0.25%)
Interpace Biosciences Announces Full Year and Fourth Quarter 2021 Financial and Business Results

 ●2021 Full Year Net Revenue of $41.3 Million up 28% vs Prior Year; Fourth Quarter Net Revenue of $10.9 Million up 13% vs Prior Year  ●2021 Full Year Net...

IDXG : 1.3700 (-0.25%)
Assure Holdings Corp. (IONM) Reports Q4 Loss, Tops Revenue Estimates

Assure Holdings Corp. (IONM) delivered earnings and revenue surprises of -50% and 8.53%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

IONM : 0.5130 (+0.59%)
IDXG : 1.3700 (-0.25%)
LifeMD, Inc. (LFMD) Reports Q4 Loss, Misses Revenue Estimates

LifeMD, Inc. (LFMD) delivered earnings and revenue surprises of 25.64% and 0.11%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

LFMD : 7.95 (+1.27%)
IDXG : 1.3700 (-0.25%)
Interpace Biosciences Terminates Rights Offering Announces Change in CMS Medicare Reimbursement of its Thyroid Tests

PARSIPPANY, NJ, Jan. 28, 2022 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (OTCQX: IDXG) (“Interpace” or the “Company”) a leader in enabling...

IDXG : 1.3700 (-0.25%)

Business Summary

Interpace Biosciences Inc. is enabling personalized medicine, offering specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted therapeutic applications. Its clinical services include molecular diagnostic tests, bioinformatics, and pathology services....

See More

Key Turning Points

3rd Resistance Point 1.4533
2nd Resistance Point 1.4367
1st Resistance Point 1.4033
Last Price 1.3700
1st Support Level 1.3533
2nd Support Level 1.3367
3rd Support Level 1.3033

See More

52-Week High 3.5400
Fibonacci 61.8% 2.4799
Fibonacci 50% 2.1525
Fibonacci 38.2% 1.8250
Last Price 1.3700
52-Week Low 0.7650

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar